Rutgers scientists identify structure of virus that could lead to hepatitis C vaccine

Infection is a major global health problem affecting 160 million people worldwide

2014-02-19

(Press-News.org) Rutgers University scientists have determined the structure of a hepatitis C surface protein, a finding that could assist in the development of a vaccine to halt the spread of the the deadly disease that has infected 3.2 million Americans.

Joseph Marcotrigiano, associate professor of chemistry and chemical biology, says this new research – published online today in Nature – describes an outer region of hepatitis C that enables the virus to evade the body's natural immune system response, causing persistent, chronic infection.

Hepatitis C is constantly mutating, allowing it to infect a host cell and evade the immune responses, causing chronic infection that can be difficult to treat. By identifying the structure of virus's outer protein, Marcotrigiano, the study's lead author, says scientists will be better able to develop a vaccine that targets the immune system to vulnerable regions of the virus in order to prevent infection.

"Viruses are smart and it is a constant battle to keep them out," says Marcotrigiano who collaborated on the research with colleagues from the Center for Advanced Biotechnology and Medicine at Rutgers and Emory University School of Medicine. "That's why the development of a vaccine is so important. It's always better to prevent infection through an effective vaccine then to treat after a chronic infection has been established."

Hepatitis C virus is a major global health problem with 160 million people infected throughout the world, about four times more individuals than those with HIV. Most of those infected do not show symptoms until the virus – the number one cause of liver transplantation – has caused severe liver damage.

The virus is mainly spread through contact with an infected person's blood, such as sharing of needles. Prior to 1992, when donated blood began being tested, the virus was also spread through blood transfusions and organ donation.

Recently, the Food and Drug Administration approved several new drugs that could cure many patients infected with hepatitis C in as little as 12 weeks. However, at about $1000 per pill, this may not be a cost-effective solution to hepatitis C virus.

Developing a vaccine against hepatitis C would not only prevent people from acquiring the disease, Marcotrigiano says, but would also be the most cost-conscious health intervention.

Michael Houghton, a researcher at the University of Alberta in Canada, has been developing a vaccine that is currently being tested clinically. Houghton, who led a team that discovered the hepatitis C virus in 1989, says the Rutgers finding is important because knowing the structure of the virus will help in the development of a vaccine that enables the immune system to produce more infection-fighting antibodies that can neutralize the virus.

INFORMATION: END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

The ups and downs of early atmospheric oxygen

2014-02-19

RIVERSIDE, Calif. — A team of biogeochemists at the University of California, Riverside, give us a nontraditional way of thinking about the earliest accumulation of oxygen in the atmosphere, arguably the most important biological event in Earth history. A general consensus asserts that appreciable oxygen first accumulated in Earth's atmosphere around 2.3 billion years ago during the so-called Great Oxidation Event (GOE). However, a new picture is emerging: Oxygen production by photosynthetic cyanobacteria may have initiated as early as 3 billion years ago, with oxygen ...

NuSTAR telescope takes first peek into core of supernova

2014-02-19

Astronomers for the first time have peered into the heart of an exploding star in the final minutes of its existence. The feat is one of the primary goals of NASA's NuSTAR mission, launched in June 2012 to measure high-energy X-ray emissions from exploding stars, or supernovae, and black holes, including the massive black hole at the center of our Milky Way Galaxy. The NuSTAR team reported in this week's issue of the journal Nature the first map of titanium thrown out from the core of a star that exploded in 1671. That explosion produced the beautiful supernova remnant ...

Managed honeybees linked to new diseases in wild bees

2014-02-19

Diseases that are common in managed honeybee colonies are now widespread in the UK's wild bumblebees, according to research published in Nature. The study suggests that some diseases are being driven into wild bumblebee populations from managed honeybees. Dr Matthias Fürst and Professor Mark Brown from Royal Holloway University of London (who worked in collaboration with Dr Dino McMahon and Professor Robert Paxton at Queen's University Belfast, and Professor Juliet Osborne working at Rothamsted Research and the University of Exeter) say the research provides vital information ...

Gene sequencing project discovers common driver of a childhood brain tumor

2014-02-19

(MEMPHIS, Tenn. – February 19, 2014) The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified the most common genetic alteration ever reported in the brain tumor ependymoma and evidence that the alteration drives tumor development. The research appears February 19 as an advanced online publication in the scientific journal Nature. The results provide a foundation for new research to improve diagnosis and treatment of ependymoma, the third most common brain tumor in children. St. Jude has begun work to translate the ...

Managing chronic bone and joint pain

2014-02-19

ROSEMONT, Ill.—Musculoskeletal pain of the bone, joint and muscles is one of the most common reasons for primary care visits in the United States. According to a literature review appearing in a recent issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), chronic pain, or pain that persists beyond an expected period of healing, is estimated to affect 100 million Americans. The majority of chronic pain complaints concern the musculoskeletal system, but they also include headaches and abdominal pain. "As orthopaedic surgeons, we are experts in the ...

Blood pressure medications given right after stroke not beneficial, study finds

2014-02-19

MAYWOOD, IL – A major study has found that giving stroke patients medications to lower their blood pressure during the first 48 hours after a stroke does not reduce the likelihood of death or major disability. The study is published in the Journal of the American Medical Association. At least 25 percent of the population has high blood pressure, which greatly increases the risk of stroke. Lowering blood pressure has been shown to reduce the risk of stroke. The study investigated whether there also would be a benefit to lowering blood pressure immediately after a stroke. The ...

Reasons for becoming self-employed in later life vary by gender, culture

2014-02-19

COLUMBIA, Mo. – Self-employment can allow older workers to stay in the labor market longer and earn additional income, yet little research has addressed if reasons for self-employment vary across gender and culture. Now, University of Missouri researchers have studied factors that contribute to self-employment and found these factors differ for men and women in the United States and New Zealand. "Gender is one of the most enduring social factors in the U.S. and New Zealand, a fact that is particularly evident in differing economic opportunities for men and women and their ...

Newly developed chemical restores light perception to blind mice

2014-02-19

Progressive degeneration of photoreceptors—the rods and cones of the eyes—causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders. The retina has three layers of nerve ...

Study reveals workings of working memory

2014-02-19

PROVIDENCE, R.I. [Brown University] — Keep this in mind: Scientists say they've learned how your brain plucks information out of working memory when you decide to act. Say you're a busy mom trying to wrap up a work call now that you've arrived home. While you converse on your Bluetooth headset, one kid begs for an unspecified snack, another asks where his homework project has gone, and just then an urgent e-mail from your boss buzzes the phone in your purse. During the call's last few minutes these urgent requests — snack, homework, boss — wait in your working memory. ...

New sitting risk: Disability after 60

2014-02-19

CHICAGO --- If you're 60 and older, every additional hour a day you spend sitting is linked to doubling the risk of being disabled -- regardless of how much moderate exercise you get, reports a new Northwestern Medicine® study. The study is the first to show sedentary behavior is its own risk factor for disability, separate from lack of moderate vigorous physical activity. In fact, sedentary behavior is almost as strong a risk factor for disability as lack of moderate exercise. If there are two 65-year-old women, one sedentary for 12 hours a day and another sedentary ...

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

Rutgers scientists identify structure of virus that could lead to hepatitis C vaccine

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: